Combined use of anti-VEGF and Anti-EGFR monoclonal antibodies with Photodynamic therapy suppresses tumor growth in an in vivo tumor model

Journal of Cancer Science and Therapy

Volumn 5, Issue 3, 2013, Pages 100-105

  Bhuvaneswari, Ramaswamy ^a   Thong, Patricia ^a   Yuen, Gan Yik ^b   Olivo, Malini ^c   Chee, Soo Khee ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

Angiogenesis; Bevacizumab; Cetuximab; Epidermal growth factor receptor (EGFR); Photodynamic therapy (PDT); Vascular endothelial growth factor (VEGF)

Indexed keywords

BEVACIZUMAB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPERICIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; BLOOD VESSEL; CANCER INHIBITION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRRADIATION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84875286224     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000192     Document Type: Article

References (30)

1. Jerjes W, Upile T, Hamdoon Z, Nhembe F, Bhandari R, et al. (2009) Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study. Lasers Surg Med 41: 612-621.
2. Chen B, Pogue BW, Hoopes PJ, Hasan T (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16: 279-305.
3. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, et al. (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889-905.
4. Gollinick SO, Evans SS, Baumann H, Owczarczak B, Maier P, et al. (2003) Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88: 1772-1779.
5. Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49: 407-424.
6. Larsen AK, Ouaret D, El Ouadrani K, Petitprez A (2011) Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther 131: 80-90.
7. Shaheen RM, Ahmad SA, Liu W, Reinmuth N, Jung YD, et al. (2001) Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85: 584-589.
8. Yokoi K, Thaker PH, Yazici S, Rebhun RR, Nam DH, et al. (2005) Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Cancer Res 65: 3716-3725.
9. Naumov GN, Nilsson MB, Cascone T, Briggs A, Straume O, et al. (2009) Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res 15: 3484-3494.
10. Argiris A, Kotsakis AP, Hoang T, Worden FP, Savvides P, et al. (2013) Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol 24: 220-225.
11. Moghissi K, Dixon K, Thorpe JA, Stringer M, Oxtoby C (2007) Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax 62: 391-395.
12. Biel MA (2007) Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 83: 1063-1068.
13. Huang Z (2005) A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4: 283-293.
14. Ferrario A, Gomer CJ (2006) Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Pathol Toxicol Oncol 25: 251-259.
15. Ferrario A, Fisher AM, Rucker N, Gomer CJ (2005) Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 65: 9473-9478.
16. Gomer CJ, Ferrario A, Luna M, Rucker N, Wong S (2006) Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg Med 38: 516-521.
17. Lu C, Kamat AA, Lin YG, Merritt WM, Landen CN, et al. (2007) Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 13: 4209-4217.
18. Vallbohmer D, Zhang W, Gordon M, Yang DY, Yun J, et al. (2005) Molecular determinants of cetuximab efficacy. J Clin Oncol 23: 3536-3544.
19. Ellis LM, Hoff PM (2004) Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer. J Clin Oncol 22: 1177-1179.
20. Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T (2006) Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res 66: 5633-5640.
21. Tsai T, Ji HT, Chiang PC, Chou RH, Chang WS, et al. (2009) ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells. Lasers Surg Med 41: 305-315.
22. Ahmad N, Kalka K, Mukhtar H (2001) In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy. Oncogene 20: 2314-2317.
23. Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, et al. (2004) Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 64: 2120-2126.
24. Press MF, Lenz HJ (2007) EGFR, HER2 and VEGF pathways: validated targets for cancer treatment. Drugs 67: 2045-2075.
25. Patel D, Bassi R, Hooper A, Prewett M, Hicklin DJ, et al. (2009) Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation. Int J Oncol 34: 25-32.
26. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE (1999) ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem 274: 17209-17218.
27. Hoffman A, Goetz M, Vieth M, Galle PR, Neurath MF, et al. (2006). Confocal laser endomicroscopy: technical status and current indications. Endoscopy 38: 1275-1283.
28. Goetz M, Thomas S, Heimann A, Delaney P, Schneider C, et al. (2008) Dynamic in vivo imaging of microvasculature and perfusion by miniaturized confocal laser microscopy. Eur Surg Res 41: 290-297.
29. Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, et al. (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human Transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5: 257-264.
30. Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, et al. (2002) Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Clin Cancer Res 8: 1253-1264.